Plaquenil is used to treat or prevent malaria, a disease caused by parasites that enter the body through the bite of a mosquito. Malaria is common in areas such as Africa, South America, and Southern Asia. Plaquenil product monograph canada Chloroquine dosage ophthalmology guidelines Immunosuppressant drugs are a class of drugs that suppress, or reduce, the strength of the body’s immune system. Some of these drugs are used to make the body less likely to reject a. Find patient medical information for Plaquenil Oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings. Hydroxychloroquine HCQ, sold under the brand name Plaquenil among others, is a medication used for the prevention and treatment of certain types of malaria. Specifically it is used for chloroquine-sensitive malaria. Other uses include treatment of rheumatoid arthritis, lupus, and porphyria cutanea tarda. It is taken by mouth. Plaquenil is also an antirheumatic medicine and is used to treat symptoms of rheumatoid arthritis and discoid or systemic lupus erythematosus. This medicine is not effective against all strains of malaria. Is plaquenil considered an immunosuppressant Healthboards - Immune & Autoimmune - Lupus Plaquenil., Plaquenil Oral Uses, Side Effects, Interactions, Pictures. Can plaquenil help mononucleosisMethylene blue falciparum chloroquine sensitizeDmards plaquenil Plaquenil hydroxychloroquine is considered an older DMARD disease modifying anti-rheumatic drug. Plaquenil was actually first classified as an antimalarial drug, but it is also used to treat certain rheumatic and autoimmune conditions which are unrelated to malaria. Taking Plaquenil for Rheumatoid Arthritis. Hydroxychloroquine - Wikipedia. Hydroxychloroquine Plaquenil. The answer was that while Hydroxychloroquine, the generic name for Plaquenil and the tablet I take in the same dose as yourself i.e. 200mg a day at the moment, is a disease modifying drug and an anti-malarial, it is also a mild immunosuppressant too. So this could be why your immune system is so low at the moment. Monitor patients for cardiomyopathy during PLAQUENIL therapy. Chronic toxicity should be considered when conduction disorders bundle branch block/atrio-ventricular heart block or biventricular hypertrophy are diagnosed. If cardiotoxicity is suspected, prompt discontinuation of PLAQUENIL may prevent life-threatening complications. PLAQUENIL is useful in patients with the following disorders who have not responded satisfactorily to drugs with less potential for serious side effects lupus erythematosus chronic discoid and systemic and acute or chronic rheumatoid arthritis.